Northeast Investment Management Lowers Holdings in The Clorox Company $CLX

Northeast Investment Management decreased its position in shares of The Clorox Company (NYSE:CLX) by 20.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,489 shares of the company’s stock after selling 8,597 shares during the quarter. Northeast Investment Management’s holdings in Clorox were worth $4,252,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in CLX. Savvy Advisors Inc. raised its holdings in shares of Clorox by 1.4% in the 2nd quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock valued at $768,000 after purchasing an additional 91 shares in the last quarter. Canandaigua National Bank & Trust Co. increased its holdings in Clorox by 0.8% during the third quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock valued at $1,380,000 after buying an additional 94 shares during the period. State of Michigan Retirement System raised its stake in Clorox by 0.3% in the second quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock worth $4,028,000 after buying an additional 100 shares in the last quarter. Blue Trust Inc. lifted its holdings in Clorox by 8.5% during the third quarter. Blue Trust Inc. now owns 1,333 shares of the company’s stock worth $164,000 after buying an additional 104 shares during the period. Finally, Westhampton Capital LLC lifted its holdings in Clorox by 0.5% during the third quarter. Westhampton Capital LLC now owns 23,150 shares of the company’s stock worth $2,854,000 after buying an additional 107 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on CLX shares. Deutsche Bank Aktiengesellschaft reduced their price target on Clorox from $114.00 to $112.00 and set a “hold” rating for the company in a research report on Wednesday, February 4th. Citigroup boosted their target price on shares of Clorox from $109.00 to $115.00 and gave the stock a “neutral” rating in a report on Wednesday, February 4th. Royal Bank Of Canada set a $132.00 price target on shares of Clorox in a research report on Wednesday, February 4th. BNP Paribas Exane raised shares of Clorox from an “underperform” rating to a “neutral” rating in a research report on Wednesday, February 11th. Finally, Morgan Stanley raised their price objective on Clorox from $125.00 to $136.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 5th. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, Clorox currently has an average rating of “Reduce” and an average target price of $118.73.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were bought at an average price of $104.13 per share, for a total transaction of $416,520.00. Following the acquisition, the director owned 13,000 shares in the company, valued at $1,353,690. This represents a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.63% of the stock is owned by company insiders.

Clorox Trading Down 2.3%

NYSE:CLX opened at $123.00 on Wednesday. The company has a market capitalization of $14.87 billion, a P/E ratio of 20.10, a PEG ratio of 0.62 and a beta of 0.59. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03. The Clorox Company has a 12 month low of $96.66 and a 12 month high of $159.04. The firm has a fifty day simple moving average of $108.56 and a 200-day simple moving average of $113.55.

Clorox (NYSE:CLX) last released its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the company earned $1.55 earnings per share. Clorox’s revenue was down .8% on a year-over-year basis. On average, equities research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.